BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32499530)

  • 1. HOXA5 inhibits the proliferation and neoplasia of cervical cancer cells via downregulating the activity of the Wnt/β-catenin pathway and transactivating TP53.
    Ma HM; Cui N; Zheng PS
    Cell Death Dis; 2020 Jun; 11(6):420. PubMed ID: 32499530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
    Li L; Yang WT; Zheng PS; Liu XF
    Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
    Chen M; Li L; Zheng PS
    Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HNF4A Regulates the Proliferation and Tumor Formation of Cervical Cancer Cells through the Wnt/
    Ma HM; Zhang Q; Yang XM; Hu Y; Zhang J; Chen L; Zhao B; Yang WT; Xu R
    Oxid Med Cell Longev; 2022; 2022():8168988. PubMed ID: 35132353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression.
    Cui N; Yang WT; Zheng PS
    Oncotarget; 2016 May; 7(18):26152-67. PubMed ID: 27036045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOXB4 inhibits the proliferation and tumorigenesis of cervical cancer cells by downregulating the activity of Wnt/β-catenin signaling pathway.
    Lei D; Yang WT; Zheng PS
    Cell Death Dis; 2021 Jan; 12(1):105. PubMed ID: 33479226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/β-catenin pathway via GSK3β.
    Liu XF; Li XY; Zheng PS; Yang WT
    Cell Death Dis; 2018 Mar; 9(3):339. PubMed ID: 29497051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
    Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
    Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXA5 inhibits the proliferation and metastasis of cervical squamous cell carcinoma by suppressing the β-catenin/Snail signaling.
    Jin WY; Zhang Y; Tian J; Xu LK; Lin HJ; Yang YZ; Zhang XM; Jin MH; Mo WF; Qi GY; Zhou YQ
    Neoplasma; 2023 Feb; 70(1):82-93. PubMed ID: 36660797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathway.
    Chen Q; Cao HZ; Zheng PS
    Oncotarget; 2014 Oct; 5(19):9092-105. PubMed ID: 25193857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression.
    Wang Q; Qin Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Zhou D; He J
    Cell Death Dis; 2018 Jun; 9(6):668. PubMed ID: 29867145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of HOXA5 inhibits the tumorigenesis in esophageal squamous cell cancer.
    Zhang H; Zhao JH; Suo ZM
    Biomed Pharmacother; 2017 Feb; 86():149-154. PubMed ID: 27960137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of long noncoding RNA DGCR5 contributes to the proliferation, migration, and invasion of cervical cancer by activating Wnt signaling pathway.
    Liu Y; Chang Y; Lu S; Xiang YY
    J Cell Physiol; 2019 Jul; 234(7):11662-11669. PubMed ID: 30552671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
    Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/β-catenin pathway in cervical carcinoma cells.
    Li R; Li P; Wang J; Liu J
    Life Sci; 2020 Oct; 258():118190. PubMed ID: 32777299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway.
    Zhang YS; Xie JZ; Zhong JL; Li YY; Wang RQ; Qin YZ; Lou HX; Gao ZH; Qu XJ
    Biochim Biophys Acta; 2013 Jun; 1830(6):3604-15. PubMed ID: 23500016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.